Great Weekend Reads From KHN
KHN's newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don't have to.
Drugs
1,021-1,040 of 1,323 results
-
-
KHN On C-SPAN: Current Capitol Hill Thinking On Combating The Opioid Crisis
KHN鈥檚 Shefali Luthra offers insight into what federal and state officials are eyeing to help reduce addiction problems.
-
How A Drugmaker Turned The Abortion Pill Into A Rare-Disease Profit Machine
An abortion drug invented decades ago is being used to treat Cushing鈥檚 syndrome 鈥 and it鈥檚 bringing in tens of millions of dollars a year.
-
C-SPAN: FDA Commissioner Scott Gottlieb Talks To KHN
Kaiser Health News reporter Sarah Jane Tribble sat down with Food and Drug Administration Commissioner Scott Gottlieb on C-SPAN鈥檚 "Newsmakers" program. The conversation ranged from how the nation should combat the opioid epidemic to reining in drug prices.
-
-
Patient Advocacy Groups Take In Millions From Drugmakers. Is There A Payback?
Kaiser Health News launches 鈥淧re$cription for Power,鈥 a groundbreaking database to expose Big Pharma鈥檚 ties to patient groups.
-
鈥楴ightmare Bacteria’ Stalk U.S. Hospitals
The Centers for Disease Control and Prevention found antibiotic-resistant bacteria whose spread has 鈥渙utpaced鈥 efforts to contain them.
By Liz Szabo -
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 VA Secretary Out, Privatization In?
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Sarah Kliff of Vox.com, Anna Edney of Bloomberg News and Alice Ollstein of Talking Points Memo discuss President Donald Trump鈥檚 firing of David Shulkin, the secretary of Veterans Affairs, and Shulkin鈥檚 claim that he was forced out by those who want to privatize VA health care.
-
Readers Seek Transparency On Surgery Centers, ‘Bill Of The Month’ Investigations
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 Health Law Fix Misses The Spending Bill Train
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Margot Sanger-Katz of The New York Times discuss the apparent demise of bipartisan legislation aimed at shoring up parts of the Affordable Care Act. They also discuss aggressive new efforts by the Food and Drug Administration to regulate tobacco products. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
-
Poll: Americans Aghast Over Drug Costs But Aren鈥檛 Holding Their Breath For A Fix
Almost three-quarters of Americans think the pharmaceutical industry has too much power in the nation鈥檚 capital, according to the Kaiser Family Foundation.
By Rachel Bluth -
Graphic: Opioid Painkiller Is Top Prescription In 10 States
Though opioid prescriptions appear to be on the聽decline, Vicodin and Norco remain popular, especially in the South. In more than half of states, Synthroid 鈥 a drug to treat hypothyroidism 鈥 came in at No. 1.
By Jenny Gold -
Congress Tackles The Opioid Epidemic. But How Much Will It Help?
President Trump, speaking Monday, called for a tough-on-crime federal approach. Meanwhile, on Capitol Hill, legislative strategies to combat this pressing public health problem are gaining momentum, but experts are not certain these approaches will make a difference.
-
Bill Of The Month: For Toenail Fungus, A $1,500 Prescription
How a prescription wiped out one woman鈥檚 health reimbursement account, raising questions about prescription drug price tags and about how health care professionals deal (or don鈥檛) with medical costs.
-
The Other Opioid Crisis: Hospital Shortages Lead To Patient Pain, Medical Errors
A nationwide shortage of injectable opioid painkillers has left hospitals scrambling to find alternatives 鈥 in some cases leading to dosage mistakes that may harm patients.
-
Use Of HIV-Prevention Drug Grows, But Lags Among Non-Whites
The pill, known as PrEP, can reduce the risk of contracting the virus that causes AIDS by 90 percent. Its use has expanded sharply in recent years 鈥 but primarily among a white demographic.
By Anna Gorman -
Opioid Maker Funds Efforts To Fight Addiction: Is It 鈥楤lood Money鈥 Or Charity?
Purdue Pharma, whose signature product helped fuel the opioid epidemic, now wants to help treat it 鈥 or at least salvage its own reputation.
By Jenny Gold -
Lifting Therapy Caps Is A Load Off Medicare Patients鈥 Shoulders
Last month鈥檚 budget deal means Medicare beneficiaries are eligible for physical and occupational therapy indefinitely. Plus, prescription drug costs will fall for more seniors.
By Susan Jaffe -
Patients Overpay For Prescriptions 23% Of The Time, Analysis Shows
Researchers at the University of Southern California analyzed millions of prescriptions and concluded that close to a quarter paid copays that exceeded the cost of the drugs.
-
A Battered Doctor, A Slain Patient And A Family鈥檚 Quest For Answers
An addiction-treatment physician fatally shot a troubled ex-Marine after the man pummeled him inside his California office, police records show. The tragedy illustrates how the limited number of clinics available to prescribe buprenorphine, a drug that all but erases opioid withdrawal, can become crowded, chaotic and dangerous.
By Brian Rinker